Efficacité exemplaire du rituximab dans un cas d'anémie hémolytique à autoanticorps froids

There are only few observations that have been reported in the literature regarding the efficacity of rituximab in the treatment of cold agglutinin disease. This promising therapy could, in the future, constitute a real alternative.